Clinico-pathological characteristics of patients with stage IB1–IB2 (FIGO 2018) uterine cervical cancer: a nationwide study in Japan

Clinico-pathological characteristics of patients with stage IB1–IB2 (FIGO 2018) uterine cervical cancer: a nationwide study in Japan

Objective The aim of this retrospective analysis is to reveal clinicopathological findings and clinical outcome of patients with stage IB1/IB2 (FIGO 2018) uterine cervical cancer. Methods Based on the database of the Japanese Gynecologic Oncology Group, 2194 patients with stage IB1/IB2 (FIGO 2018),...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of clinical oncology 2021-08, Vol.26 (8), p.1541-1552
Hauptverfasser: Tsuji, Keita, Shimada, Muneaki, Takahashi, Fumiaki, Tokunaga, Hideki, Deura, Imari, Yamaguchi, Satoshi, Nakanishi, Toru, Matsuo, Koji, Yaegashi, Nobuo, Mikami, Mikio
Format: Artikel
Sprache:eng
Schlagworte:
Cancer Research
Cervical cancer
Cervix
Hysterectomy
Medicine
Medicine & Public Health
Multivariate analysis
Oncology
Original Article
Patients
Risk groups
Squamous cell carcinoma
Surgical Oncology
Uterine cancer
Uterus
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective The aim of this retrospective analysis is to reveal clinicopathological findings and clinical outcome of patients with stage IB1/IB2 (FIGO 2018) uterine cervical cancer. Methods Based on the database of the Japanese Gynecologic Oncology Group, 2194 patients with stage IB1/IB2 (FIGO 2018), who underwent radical hysterectomy between 1/1/2004–12/31/2008, were identified as eligible for this retrospective study. Results Patients with squamous cell carcinoma had significantly frequent lympho-vascular space invasion than those with non-squamous cell carcinoma in both stage IB1 and IB2 (stage IB1; 29.1% vs. 17.1%, p  
ISSN:1341-9625
1437-7772
DOI:10.1007/s10147-021-01938-4